Pharmaceuticals
-
Africa’s first end-to-end mRNA facility secures SAHPRA approval
Afrigen Biologics has secured SAHPRA GMP certification for its Cape Town mRNA facility—the first end-to-end site in Africa authorised to manufacture investigational biologicals for Phase I/II trials. Discover how this milestone strengthens supply security, pandemic readiness and the WHO-MPP mRNA network.
-
Unregistered Semaglutide Tirzepatide recall: SAHPRA & SAPC seize products at Sentra Pharmacy
SAHPRA and the SAPC raided Sentra Pharmacy (Silverton, Pretoria) on 11 May 2026, seizing unregistered Semaglutide, Tirzepatide and combo GLP‑1/GIP injectables amid illegal API imports, poor sterility and no pharmacovigilance. See the enforcement steps, recall scope and risks for patients and prescribers.
-
Cleanroom solutions Africa: Turnkey expertise by AFMS
AFMS, based in Midrand, South Africa, has been a trusted provider of cleanroom and containment solutions for over 40 years. Specialising in modular, mobile, and permanent facilities, AFMS delivers turnkey solutions across Africa and beyond.
-
Introducing the Glatt GSX pharma spray dryer
Meet the Glatt GSX pharma spray dryer—built with pharmacists for pharmacists—to deliver GMP-ready design, OEB 5 containment, and reproducible scale-up. Explore how its advanced particle engineering and 21 CFR Part 11 digital control enable precise micro/nano particles, amorphous solid dispersions, and lipid-based delivery for faster, compliant tech transfer.
-
Evonik Slovakia biotechnology expansion: €80 mn investment
Evonik will introduce advanced downstream fermentation technology, enhancing the group’s drug-substance contract manufacturing capabilities. The project is expected to create around 50 new jobs, further boosting the local economy.
-
Beauty brands cross into pharmacy territory: SAPHEX signals market shift
At SAPHEX, beauty brands moved firmly into pharmacy aisles—chasing dermocosmetics, prevention-first care, and masstige shoppers as pharmacies evolve into health hubs. See how players like Nativechild are reshaping hair and body care with science-backed, locally made solutions—and what this retail shift means for your brand.
-
Manuchar to acquire CJP Chemicals in South Africa
Manuchar will acquire South Africa’s CJP Chemicals, expanding its reach across personal care, pharmaceuticals, food and beverage, and industry, pending antitrust approval for a planned Q3 2026 close. See how this deal links a $2.6bn distributor with a $100m local leader operating in Johannesburg, Durban, Cape Town and Gqeberha.
-
Ingredient-led skincare in SA: A growing trend
South African shoppers are flipping bottles for glycolic, niacinamide and retinol—not promises. Explore how ingredient-led skincare is reshaping demand, what consumers really want, and where the retail wins are, with insights from RTSC’s general manager, Nick Hunt.
-
Vaccine procurement in SA: Balancing access, affordability & local capacity
South Africa’s vaccine tenders must balance patient access, affordability, and reliable supply while building local capacity. Explore how a pragmatic mix of local and global suppliers, competitive pricing, and strict regulatory standards can secure uninterrupted immunisation and extend coverage to underserved communities—without compromising sustainability.
-
Cipla and ImmunoACT launch CAR‑T therapy in Africa
Cipla and ImmunoACT are bringing India’s first indigenous anti‑CD19 CAR‑T therapy to Africa, with commercial rollout in South Africa, Algeria and Morocco. Learn how talicabtagene autoleucel—already used in 500+ patients—could expand access to advanced treatment for relapsed B‑cell cancers with strong efficacy and a manageable safety profile.
-
Pharmaceutical innovation: Driving change with industry and academia
See how Austell Pharmaceuticals and Wits University are transforming healthcare in South Africa—empowering education, advancing research, and driving real social impact. Discover how this groundbreaking partnership is shaping the future of pharmaceutical innovation.
-
Pharmaceutical Task Group appoints new leadership
The Pharmaceutical Task Group has named Zwelethu Bashman as chairman and Dr Stavros Nicolaou as deputy chairman, marking a new chapter focused on growth, investment, and broader access to medicines in South Africa. Discover what this leadership change means for the industry’s future.
